Abstract
Run Yuan, Yinuo Zhang, Ruikang Zhong, Dianna Liu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1038/s41571-023-00798-3
10.1038/s41571-023-00798-3
10.1136/bmj-2021-068044
10.1136/bmj-2021-068044
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Small Cell Lung Cancer
2025
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer
2025
10.1016/j.annonc.2021.03.207
10.1016/j.annonc.2021.03.207
10.1002/tox.70121
10.1002/tox.70121
10.1186/s13012-024-01357-9
10.1186/s13012-024-01357-9
10.1016/j.taml.2025.100583
10.1016/j.taml.2025.100583
Unresolved referenced work
Kept as external metadata until matched
Comparative benchmarking of the DeepSeek large language model on medical tasks and clinical reasoning
2025
10.1038/s41586-023-06291-2
10.1038/s41586-023-06291-2
10.56305/001c.122787
10.56305/001c.122787
10.1038/s41591-025-03983-2
10.1038/s41591-025-03983-2
10.1038/s41591-023-02448-8
10.1038/s41591-023-02448-8
10.1001/jamanetworkopen.2023.43689
10.1001/jamanetworkopen.2023.43689
10.1016/j.ebiom.2025.105695
10.1016/j.ebiom.2025.105695
Exploring the role of large language models in the scientific method: from hypothesis to discovery
2025
10.1016/j.ebiom.2024.105441
10.1016/j.ebiom.2024.105441
Towards accurate differential diagnosis with large language models
2025
10.2196/59069
10.2196/59069
Unlocking the potential of ChatGPT: a comprehensive exploration of its applications, advantages, limitations, and future directions in natural language processing
2025
10.1038/s41746-024-01390-4
10.1038/s41746-024-01390-4
10.1038/s41591-026-04229-5
10.1038/s41591-026-04229-5
10.1186/s12911-025-02954-4
10.1186/s12911-025-02954-4
10.1038/s41746-025-02174-0
10.1038/s41746-025-02174-0
10.1001/jama.2013.7835
10.1001/jama.2013.7835
10.1097/js9.0000000000001066
10.1097/js9.0000000000001066
10.1016/j.ijnurstu.2024.104771
10.1016/j.ijnurstu.2024.104771
10.1055/a-2289-5732
10.1055/a-2289-5732
10.1038/s41746-024-01239-w
10.1038/s41746-024-01239-w
10.1038/s41746-025-01476-7
10.1038/s41746-025-01476-7
10.1016/s2665-9913(23)00216-3
10.1016/s2665-9913(23)00216-3
10.2196/90673
10.2196/90673
10.1007/s00296-025-06053-5
10.1007/s00296-025-06053-5
10.1016/j.jdent.2026.106675
10.1016/j.jdent.2026.106675
10.1007/s10067-026-08073-3
10.1007/s10067-026-08073-3
10.5435/jaaos-d-25-01242
10.5435/jaaos-d-25-01242
Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals
2025
Deepseek-v3 technical report
2024
Neoadjuvant (neoadj) osimertinib (osi) ± chemotherapy (CT) vs CT alone in resectable (R) epidermal growth factor receptor-mutated
2025
10.1038/s41746-024-01283-6
10.1038/s41746-024-01283-6 · doi-reference
10.1016/j.jksuci.2023.01.014
10.1016/j.jksuci.2023.01.014 · doi-reference
10.1038/s41591-023-02540-z
10.1038/s41591-023-02540-z · doi-reference
10.1001/jama.2021.15319
10.1001/jama.2021.15319 · doi-reference
10.1080/1750743x.2025.2580272
10.1080/1750743x.2025.2580272 · doi-reference